Dixon Translational Research Grants
The Dixon Translational Research Grants initiative seeks proposals for highly innovative, multi-disciplinary clinical and translational research collaborations to accelerate the identification and implementation of new treatments that will improve human health.
The Northwestern University Clinical and Translational Sciences (NUCATS) Institute and Northwestern Memorial Foundation (NMF) have formally announced a Request for Applications for the 2021 Dixon Translational Research Grants Initiative.
The application submission deadline is Monday, October 12, 2020, by 5:00 p.m. CT.
Three Award Classifications
Eligibility is limited to faculty of Northwestern University Feinberg School of Medicine or NMHC employees. Ann & Robert H. Lurie Children’s Hospital of Chicago and the Shirley Ryan AbilityLab faculty will be eligible to apply, provided they have appointments within the Northwestern University Feinberg School of Medicine.
New Investigator Award
Applications will be accepted from full time Feinberg faculty within the first three years of their initial faculty appointment as an Instructor or Assistant Professor (applicants must have a faculty appointment effective January 1, 2021), as well as an NMHC employee with a medical faculty co-principal investigator jointly affiliated with Northwestern Medicine.
Priority Research Initiative (PRI) proposals
PRI proposals should be multidisciplinary. They should have the capability to produce innovative outcomes in a field of strategic importance to Northwestern Medicine within the grant period of up to three years. PRI projects catalyze new ideas with high impact potential, and stimulate strong collaborations across engineers, basic science, and clinical researchers that will translate to clinical applications.
- Innovation Award: $50,000 maximum, for one year.
- New Investigator Award: $35,000 maximum, for one year.
- Priority Research Initiative: $300,000 maximum, for three years.
Ideal proposals will clearly demonstrate the following elements:
- Innovation and novelty of proposed clinical and translational research
- A strong team and appropriate infrastructure to support the project
- Strong potential to lead to meaningful impact on clinical care (successful proposals will provide a clear description of this impact)
- Clear objectives, a detailed timeline, anticipated results and outcome measures
- Priority is given to projects with near-term clinically relevant results (one to three years) or results that can be translated to patient care within one year of project completion
- A plan to secure future funding from other sources upon completion of the project
For application questions, contact Keith Herzog.
For questions regarding NITRO Competitions, email email@example.com.
Investigators seeking assistance finding collaborators or specific resources should contact Alexandra De Paz at 847-467-0320.